• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

Novalgin®

	Next higher product group	Metamizol (INN v)
	Status	1997-01-01 sales existent
	Status	1998-01-01 sales existent
	Organisation	Hoechst AG, Hoechst Marion Roussel Deutschland
	Today	Aventis Pharma Deutschland GmbH
	Group	Sanofi (Group) [since May 2011]

Record changed: 2011-11-25

Advertisement

More documents for Novalgin®

• [1] Frankfurter Rundschau (25.08.1997). “Wenn Kinder Schmerzen oder Fieber haben: Das Hoechst-Mittel Novalgin hat sehr selten, dann aber schwerwiegende Nebenwirkungen” [Schmid, Raimund]....
• [2] Document »PHIN S00003483 8200« from dababase search at host »Data-Star« in database/s »PHIN« on 10/14/97....
• [3] Document »BP80 BGA-8206« from dababase search at host »DIMDI« in database/s »BP80 (BGI-Pressedienste)« on 05/09/97....
• [4] Document »PHIN S00000511 8200« from dababase search at host »Data-Star« in database/s »PHIN« on 10/14/97....

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2013. Made in Germany.